Cargando…

Improving outcome and prognosis prediction in non-muscle invasive bladder cancer using a gene expression score

Detalles Bibliográficos
Autor principal:	Breyer, Johannes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673822/ https://www.ncbi.nlm.nih.gov/pubmed/29184802 http://dx.doi.org/10.21037/tau.2017.09.06

Ejemplares similares

FOXM1 predicts disease progression in non-muscle invasive bladder cancer
por: Rinaldetti, Sebastien, et al.
Publicado: (2018)

Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer
por: Eckstein, Markus, et al.
Publicado: (2021)

Biomarkers for the prediction of oncologic outcomes in non-muscle invasive bladder cancer: state of affairs and new frontiers
por: Soria, Francesco, et al.
Publicado: (2018)

A novel signature constructed by differential genes of muscle-invasive and non-muscle-invasive bladder cancer for the prediction of prognosis in bladder cancer
por: Wang, Weizhuo, et al.
Publicado: (2023)

High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer
por: Sikic, Danijel, et al.
Publicado: (2021)

The value of molecular markers in classification and prediction of progression in non-muscle-invasive bladder cancer
por: Pan, Chin-Chen
Publicado: (2018)

Controlling Nutritional Status Score Evaluates Prognosis in Patients With Non-Muscle Invasive Bladder Cancer
por: Huang, Jiaguo, et al.
Publicado: (2021)

Predicting the biological behavior of non-muscle-invasive bladder cancer: from histology to molecular taxonomy
por: Luchini, Claudio, et al.
Publicado: (2017)

The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer
por: Sikic, Danijel, et al.
Publicado: (2021)

Predictors of Outcome of Non–Muscle-Invasive and Muscle-Invasive Bladder Cancer
por: Youssef, Ramy F., et al.
Publicado: (2011)

Prediction of progression to muscle-invasive disease in patients with high-risk bladder cancer
por: Oszczudlowski, Maciej, et al.
Publicado: (2018)

Targeting splicing factors as molecular non-muscle invasive bladder cancer predictors
por: Lee, Kyoung-Hwa, et al.
Publicado: (2018)

Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder
por: Xylinas, E, et al.
Publicado: (2013)

Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy
por: Eckstein, Markus, et al.
Publicado: (2020)

New Roadmaps for Non-muscle-invasive Bladder Cancer With Unfavorable Prognosis
por: Pane, Katia, et al.
Publicado: (2020)

The association of BMI with risk of recurrence and progression in patients with non-muscle-invasive bladder cancer
por: Vrieling, Alina
Publicado: (2018)

Treatment strategies for the Bacillus Calmette-Guérin–unresponsive non-muscle invasive bladder cancer
por: Jeong, Seung-hwan, et al.
Publicado: (2023)

FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy
por: Sikic, Danijel, et al.
Publicado: (2020)

Gene Screening for Prognosis of Non-Muscle-Invasive Bladder Carcinoma under Competing Risks Endpoints
por: Ke, Chenlu, et al.
Publicado: (2023)

Prediction tools in non-muscle invasive bladder cancer
por: Zamboni, Stefania, et al.
Publicado: (2019)

Editorial comment: bladder preservation as a treatment strategy in muscle-invasive bladder cancer
por: Ajib, Khaled, et al.
Publicado: (2018)

Urinary biomarker for the detection of recurrence following non-muscle invasive bladder cancer: are we there yet?
por: Tan, Wei Shen, et al.
Publicado: (2018)

A single immediate instillation of chemotherapy for non-muscle invasive bladder cancer: in all patients?
por: Sylvester, Richard
Publicado: (2018)

Redefining the role of immediate intravesical instillation of mitomycin C in non-muscle invasive bladder cancer
por: Batura, Deepak
Publicado: (2018)

Combination of histological and molecular data for improving outcome prediction in non-muscle invasive bladder cancer—narrative review
por: Piszczek, Radosław, et al.
Publicado: (2020)

Decreased DBC1 Expression Is Associated With Poor Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer
por: Shim, Ui Jae, et al.
Publicado: (2013)

Classification of Muscle Invasive Bladder Cancer to Predict Prognosis of Patients Treated with Immunotherapy
por: Wang, Zhifeng, et al.
Publicado: (2022)

Next-generation sequencing in non-muscle-invasive bladder cancer—a step towards personalized medicine for a superficial bladder tumor
por: Butterfield, Andrew, et al.
Publicado: (2017)

A risk score for the prognosis prediction of the muscle-invasive bladder cancer patients who received gemcitabine plus cisplatin chemotherapy
por: Guo, Yupeng, et al.
Publicado: (2022)

FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes
por: Rinaldetti, Sebastien, et al.
Publicado: (2017)

Clinical benefit to regionalization of care for muscle invasive bladder cancer
por: Haque, Waqar, et al.
Publicado: (2018)

Opportunities of next-generation sequencing in non-muscle invasive bladder cancer outcome prediction
por: Pang, Karl H., et al.
Publicado: (2017)

Editorial on the value of an immediate intravesical instillation of mitomycin C in patients with non-muscle-invasive bladder cancer
por: Oosterlinck, Willem, et al.
Publicado: (2018)

Spinal anesthesia is associated with lower recurrence rates after resection of non-muscle invasive bladder cancer
por: Kweon, Tae Dong, et al.
Publicado: (2018)

Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer
por: Ferro, Matteo, et al.
Publicado: (2021)

Risk Prediction Scores for Recurrence and Progression of Non-Muscle Invasive Bladder Cancer: An International Validation in Primary Tumours
por: Vedder, Moniek M., et al.
Publicado: (2014)

Serum microRNA expression signatures as novel noninvasive biomarkers for prediction and prognosis of muscle-invasive bladder cancer
por: Jiang, Xiumei, et al.
Publicado: (2016)

Pyroptosis-Related Signature Predicts Prognosis and Immunotherapy Efficacy in Muscle-Invasive Bladder Cancer
por: Zhang, Qi, et al.
Publicado: (2022)

Identification and validation of immunohistochemical marker panels to predict the prognosis of muscle invasive bladder cancer
por: Ying, Yidie, et al.
Publicado: (2023)

Smoking Behaviors and Prognosis in Patients With Non–Muscle-Invasive Bladder Cancer in the Be-Well Study
por: Kwan, Marilyn L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r6tb22iolunfkr0nkvt3oga6b8